VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
about
Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degenerationAnimal models of age related macular degenerationPathogenesis of herpes stromal keratitis--a focus on corneal neovascularizationCCR3 and choroidal neovascularizationThe mouse retina as an angiogenesis model.Sustained delivery of a HIF-1 antagonist for ocular neovascularization.The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration.Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.Emerging drugs for diabetic retinopathy.Diabetic retinopathy: current management and experimental therapeutic targets.Suppression and regression of choroidal neovascularization by the multitargeted kinase inhibitor pazopanib.Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels.Neutralizing endogenous VEGF following traumatic spinal cord injury modulates microvascular plasticity but not tissue sparing or functional recovery.The alternative complement pathway regulates pathological angiogenesis in the retinaIntravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization.Oxidative stress promotes ocular neovascularization.Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculatureLoss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-ALow-dose lipopolysaccharide pretreatment suppresses choroidal neovascularization via IL-10 induction.Review of therapeutic advances in diabetic retinopathy.Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future.Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept.Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases.Double anti-angiogenic and anti-inflammatory protein Valpha targeting VEGF-A and TNF-alpha in retinopathy and psoriasis.Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptideGene transfer for neovascular age-related macular degeneration.Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-AVascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF.Aflibercept: A Review of Its Use in Diabetic Macular Oedema.A Simple Optical Coherence Tomography Quantification Method for Choroidal NeovascularizationGene Therapies for Neovascular Age-Related Macular Degeneration.Phosphatidylserine (PS) Is Exposed in Choroidal Neovascular Endothelium: PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex VivoIL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infectionOcular neovascularisation and excessive vascular permeability.Experimental study on the photodynamic treatment of choroidal neovasculization with nanophthalocyanine photosensitizer.Receptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eye.
P2860
Q26771522-AA671854-21ED-4959-99C0-E9CC3B13272BQ27004686-0D9D4992-F475-4FB0-A03A-2671AFB080ECQ27023951-A360D38F-3835-497E-805E-069EBD020CC1Q28742748-A0A259C9-9E44-412B-9C08-68F5125B7910Q30495106-17D1DE0C-2FC4-4F8C-8743-126B39CD6B18Q30560557-A30141B9-E53C-45DF-8A0C-584DB8F66B28Q31061150-6D3AC96B-379E-4644-B089-544870822890Q33212693-4B9800B2-EAFC-4A82-8CE7-ECB077E8FD53Q33237435-5A2AE845-F96C-4157-8147-127F1BD5075EQ33388498-290E75A3-E73A-4931-B9DB-05963D9EF3C3Q33403016-0A74F743-A737-478D-B7DF-740C488A106DQ33429798-B5481CE0-D94A-45C1-BCDE-DF40C67E3B8AQ33584304-DD49D505-7D00-4B86-B6AD-890207E8C332Q33619010-AB26D45D-F943-47B6-A43A-2FE3B15CD0BCQ33775122-DFA5BA40-6DA9-481A-9D47-69153C91EFDDQ33860350-2BB005FF-F1A4-4929-9A62-743E004B0DF6Q33868764-302CFECF-0293-4868-9B9B-7296F44627E2Q34000654-4EF55125-D644-403D-8F05-4B0D99DB217EQ34092454-03B09DEF-E5F9-4043-AC05-FF75B52F7A05Q34311551-82D39AD3-2B2F-4FF7-8C97-F66166947C39Q34331369-978082BD-8CBC-4F11-A36B-B7B13DDC8BDDQ34339633-8FD6CF42-A9FF-40B6-8A8D-DB18EEA30DE4Q34475449-E425A11C-0274-48F1-A9DF-DCBDD2D72DDFQ34554380-3D35E3DE-C426-4C1B-BA94-0BBBFF10F1D9Q34642583-D324CC9C-30B7-458F-938E-3035BC3BB6C8Q34658699-B8A3C7A4-553E-44DD-A127-C110F0E408FCQ34800330-22AE5349-A654-4093-9482-90F99DDCA379Q34816580-25B03730-2F36-4C93-B732-9364DAC95543Q34843778-27C78B2C-C2CD-4DAF-822D-6B91366EB538Q35024891-05B2BE99-2223-4F3F-9F25-80FE84CCF26EQ35049227-7E4336BB-AFDC-42E7-9AF2-6B69A0BB0BDEQ35191520-EA5E53F7-0FD5-43ED-A3C4-9B2AF9A6D54FQ35657595-FB0131ED-F670-4994-B5CB-E5031CD66950Q35659330-F4B64862-4D84-408E-A56D-7D4121BB51D8Q35795572-81D5A2D4-8033-4491-935E-33C6C031B713Q35830423-784C1DB2-F034-4B7D-A850-5B2239F214EDQ35850771-618161B7-5F60-4D41-95FE-FDDB448B0D35Q35873752-BD0CC104-84CC-495B-BCCB-9C3536EB841FQ35924097-05D7B700-ED33-4A4F-9C7E-16FC3F958441Q36016325-FFF558DF-978C-4113-AA36-0DC07E601D94
P2860
VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
VEGF-TRAP(R1R2) suppresses cho ...... of the blood-retinal barrier.
@ast
VEGF-TRAP(R1R2) suppresses cho ...... of the blood-retinal barrier.
@en
type
label
VEGF-TRAP(R1R2) suppresses cho ...... of the blood-retinal barrier.
@ast
VEGF-TRAP(R1R2) suppresses cho ...... of the blood-retinal barrier.
@en
prefLabel
VEGF-TRAP(R1R2) suppresses cho ...... of the blood-retinal barrier.
@ast
VEGF-TRAP(R1R2) suppresses cho ...... of the blood-retinal barrier.
@en
P2093
P356
P1476
VEGF-TRAP(R1R2) suppresses cho ...... of the blood-retinal barrier.
@en
P2093
Donna Hylton
John S Rudge
Kyoichi Takahashi
Peter A Campochiaro
Raquel Lima e Silva
Stanley J Wiegand
Yoshitsugu Saishin
Yumiko Saishin
P304
P356
10.1002/JCP.10246
P577
2003-05-01T00:00:00Z